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Abstract
Europe, because of its geographical location, strategic position on trade routes, and colonial past, has a long history of caring for travel-
lers’ health. Within Europe, there is great diversity in the practice of travel medicine. Some countries have travel medicine societies and
provisions for a periodic distribution of recommendations, but many countries have no national pre-travel guidelines and follow interna-
tional recommendations such as those provided by the WHO. Providers of travel medicine include tropical medicine specialists, general
practice nurses and physicians, specialist ‘travel clinics’, occupational physicians, and pharmacists. One of the core functions of the Euro-
pean Centre for Disease Prevention and Control-funded network of travel and tropical medicine professionals, EuroTravNet, is to doc-
ument the status quo of travel medicine in Europe. A three-pronged approach is used, with a real-time online questionnaire, a
structured interview with experts in each country, and web searching.
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Introduction
Europe, because of its geographical location, strategic posi-
tion on trade routes, and colonial history, has a long history
in caring for travellers’ health. The practice of ‘quarantine’
(Italian quaranta giorne, 40 days) was invented in Italy [1], and
this precaution against travel-associated disease was prac-
tised widely in the ports of fourteenth-century Europe
(1348, Venice; 1377, Ragusa; and 1383, Marseille). Disease is
not a one-way ‘traveller’, and mobility can lead to morbidity
in both the source and receiving countries.
Europeans have been stricken by imported diseases that
spread rapidly throughout Europe, such as the fourteenth-
century Black Death (plague), which originated in Asia, and
the sixteenth-century syphilis epidemic, which came from
America (but possibly originated in Europe). On the other
hand, Europeans have exported and spread diseases such as
measles and smallpox [2–4]. In the last century, the health of
the colonial traveller was of great importance. The Living-
stone exhibition in London (January, 1900) presented an
extravagant array of travel medicine ‘commodities’ and pre-
travel advice to assist travellers in maintaining health and
hygiene in the ‘deadly tropics’ [5]. Burroughs Wellcome &
Co. displayed their hugely successful ‘Tabloid medical chest’
(Fig. 1), which contained essential travel medicines in innova-
tive tablet form (as opposed to old-fashioned powders) that
could be used for ‘the air, for the earth, for the depths, and
for every clime under every condition’. Returning ill travellers
were treated at European tropical medicine schools and hos-
pitals [6] that specialized in diseases of the ‘tropics’, such as
FIG. 1. ‘Tabloid ﬁrst aid’—Burroughs Welcome’s Tabloid medicine
chest (Welcome Library, London).
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malaria (also endemic in parts of Europe at that time) and ﬁl-
ariasis; and in 1889, Sir Patrick Manson published his Manual
of Tropical Disease [7]. In the twentieth century, with the
increasing ease of travel, the need to provide medical care
for travellers, both before and after travel, increased expo-
nentially. Business and leisure travel in Europe became part
of a ‘desirable lifestyle’, and was facilitated by the prolifera-
tion of low-cost airline travel. High rates of immigration into
Europe led to intermingled populations with a strong demand
for visits to friends and relatives (VFR). The WHO publishes
an annual volume entitled International Travel and Health,
which aims to meet the needs of national health administra-
tions, practising travel health advisors, tourist agencies, ship-
ping companies, airline operators, and all who are called
upon to give health advice to travellers (http://www.who.int/
ith). The revised International Health Regulations [8] came
into force with the aim of helping the international commu-
nity to prevent and respond to acute public health risks that
have the potential to cross borders and threaten interna-
tional health. New health risks, such as the novel H5N1 avian
inﬂuenza virus and the pandemic H1N1 inﬂuenza virus, have
enormous implications for travel and public health.
Today, in the 21st century, travel is faster and easier. To tra-
vel around the world takes 36 hours rather than the fanciful
80 days of Jules Verne’s Europe in 1873 [9]. There are several
players in travel medicine, including general practice health
professionals, national and international authorities, occupa-
tional health advisors, and the travel industry itself [10]. Travel
health is an increasingly complex specialty, and encompasses
the identiﬁcation and epidemiology of travel-associated disor-
ders and diseases and their geographical distribution [11], the
pre-travel prevention of these conditions through education,
vaccination, chemoprophylaxis, and self-treatment (for certain
conditions), and ﬁnally the care of the returned ill traveller or
the newly arrived migrant or refugee. Disease surveillance is of
increasing importance, and two networks, EuroTravNet
(http://www.eurotravnet.eu) and TropNetEurop (http://
www.tropnet.net), monitor the epidemiology of travel-associ-
ated illness in Europe. In this post-colonial era, migration care
is an integral part of travel medicine, and several European
institutions have particular expertise in migration medicine.
Travel within, from and to Europe
Europe is the worldwide continental leader in outbound trip
volume and international tourism expenditure [12]. Germany
generates the most travel-associated spending, 59 billion eu-
ros in 2006, as compared with the USA (57 billion) and the
UK (50 billion). Other European nations in the top ten
spenders ranking were France, Italy, and the Russian Federa-
tion. In 2006, a total of 475 million Europeans travelled
internationally (402.1 million within Europe, 24 million to the
Americas, 21.2 million to Asia and the Paciﬁc, 16.8 million to
Africa, and 11.2 million to the Middle East). In 2006, more
than 462 million arrivals were registered in Europe; 53%
were travelling for leisure, 17% for business, and, impor-
tantly, more than 30% were in the visiting friends and rela-
tives (VFR) category. Travel within Europe has many
implications for health. Over 23 million Germans visit the
Mediterranean area each year, which involves risks such as
diarrhoea, hepatitis A, papataci fever, echinococcosis, and
leishmaniasis, and visitors to northern and central Europe
face the risk of tick-borne encephalitis.
Proﬁle of Travel-Associated Illness in
Europeans Travelling to Tropical Areas
The epidemiology of travel-related infectious diseases in over
17 000 returned European travellers who were ill and pre-
sented to EuroTravNet/GeoSentinel sites during the period
1997–2007 has recently been published [13]. Gastrointestinal
illness (particularly in tourists), fever (in those visiting friends
and relatives) and skin disorders (in tourists) were the most
common reasons for presentation in European travellers.
Diagnoses varied according to region visited; this regional
distribution was most pronounced for acute diarrhoea and
some other diagnoses, including malaria, dengue fever, chi-
kungunya fever, rickettsioses, salmonellosis, animal-related
injuries requiring post-exposure prophylaxis for rabies, larva
migrans, leishmaniasis, myasis, respiratory syndromes, genito-
urinary and sexually transmitted diseases, schistosomiasis,
and cerebromeningeal infections. Diagnoses also varied
according to country of origin and categories of travellers. Ill
VFR travellers who returned from sub-Saharan Africa and
the Indian Ocean Islands were far more likely to experience
Plasmodium falciparum malaria than any other group.
Interestingly, signiﬁcant ORs were observed for European
travellers as opposed to non-European travellers, in the con-
text of likelihood of acquiring certain travel-associated infec-
tious diseases. Immigrant travellers account for a large
proportion of patients. Fever is the main presenting symp-
tom of European immigrants. Signiﬁcant ORs for dengue
fever, malaria, salmonelloses, genitourinary diseases, respira-
tory disorders and dermatological symptoms were observed
for European travellers as compared with non-European
travellers. European travellers, many originating from sub-
Saharan Africa, differ from travellers outside Europe mainly
because of the characteristics of their immigrant communi-
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ties. Physicians in Europe who provide pre-travel advice and
who care for returned travellers need to be aware of the
expected proﬁle of travel-associated illness in Europe.
Why is the European Centre for Disease
Prevention and Control (ECDC) Interested
in Travel Medicine?
Travel medicine is an emerging specialty. It includes a wide
range of aspects of disease related to travel. Many of these
aspects are outside the scope of the ECDC, but others, con-
cerned not only with prevention of infectious diseases during
travel but also with risk assessment of imported infectious
threats, are related to its mission. According to Article 3 of
its founding Regulation, the ‘ECDC’s mission is to identify,
assess and communicate current and emerging threats to
human health posed by infectious diseases’ [14]. The experi-
ence of the ECDC has shown that many of these threats are
related to human mobility [15].
Travel health clinics that provide up-to-date advice on
risk and risk reduction can be effective in preventing dis-
ease [16] and can even be cost-effective [17]. However, the
epidemiology of infectious disease risks to the traveller
changes rapidly and continuously [18]; those giving travel
health advice need to ensure access to up-to-date authori-
tative sources of information and recommendations. Many
countries and organizations, including European Union (EU)
member states and the WHO (http://www.who.int/ith/en/),
produce such recommendations; some of these are reliable,
but others are outdated. There are several institutions in
the EU and outside the EU dealing with travel medicine,
and it is important for the ECDC to evaluate the possible
added value of being involved in the ﬁeld. To identify gaps
in the practice of European travel medicine in which the
ECDC could play a role, a global picture of community
expertise, of the structures and agencies already issuing
advice, as well as an evaluation of the accuracy and useful-
ness of the information provided, should be taken into
account in order to avoid duplication of effort (Article 6 of
the ECDC’s founding Regulation) [14].
Certain roles for the ECDC in this ﬁeld have already been
identiﬁed. Imported communicable diseases pose a threat,
not only to Europeans travelling abroad, but also to persons
exposed to returned travellers who carry contagious disease.
Secondary cases of many imported infections in Europe are
rare, given the absence of essential vectors in the life cycles
of organisms and good sanitary conditions, but new circum-
stances, such as the introduction of vectors, migratory
waves, and intensiﬁed international travel, make onward
transmission of imported infections more likely. A good
example of how an imported case can lead to a generalized
outbreak was the autochthonous transmission of chikungu-
nya virus in Italy in August 2007 [18]. The presence of Aedes
albopictus in Europe [19] highlights the need for a continuous
awareness of dengue and chikungunya virus infection, as
imported cases may result in secondary cases occurring
within the EU. In monitoring these and other travel-related
health threats, ECDC may need advice and guidance for risk
assessment and risk communication from tropical and travel
medicine experts to improve assessment and response [15].
The SARS outbreak in 2003 illustrated how quickly a new
virus could spread internationally in the modern age [20].
This was one of the reasons why the EU decided to establish
the ECDC: to help strengthen Europe’s defences against
future disease outbreaks, which are a constant threat for vul-
nerable populations, and against many diseases that affect an
immunologically naive European population [14].
To fulﬁl these tasks, the ECDC has established collabora-
tion through a public tender with EuroTravNet (http://
www.eurotravnet.eu), a network of travel health experts,
which supports the ECDC by providing expert advice con-
cerning the detection, veriﬁcation, assessment and communi-
cation of communicable diseases that can be associated
with travel and, speciﬁcally, with tropical diseases (http://ecdc.
europa.eu/en/aboutus/calls/Lists/Calls%20for%20tender/ECDC_
DispForm.aspx?List=a70e951a%2D9260%2D4909%2Dbc27%
2Dcefd2af6e9a4&ID=301&RootFolder=%2Fen%2Faboutus%
2Fcalls%2FLists%2FCalls%20for%20tender). The network will
establish a European inventory of travel medicine providers
and resources in the EU, the European Free Trade Associa-
tion, and candidate states [21].
How EuroTravNet Aims to Document the
Status Quo of Travel Medicine in Europe
In this, the ﬁrst year, of EuroTravNet’s existence, one of the
primary goals is to establish a European inventory of travel
medicine providers and resources, using a systematic three-
pronged approach:
1. Real-time data are collated with an online, internet-based
questionnaire (http://www.surveymonkey.com/s.aspx?sm=
t3HkKAnexJxKme6ap7GBUg_3d_3d) (consisting of ten
questions), the responses to which are entered into a
database. The questionnaire is available at http://
www.surveymonkey.com/s.aspx?sm=t3HkKAnexJxKme6ap7
GBUg_3d_3d. In brief, the questionnaire provides data
on demographics, the type of travel medicine practice/
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institution, the variety of travel health services provided
(pre-travel/post-travel, yellow fever vaccination, etc.), the
proﬁle of travellers seen, the numbers of travellers seen
prior to or after travel, the number of yellow fever vac-
cinations administered, speciﬁc health sevices that are
offered for migrants, and a record of the research and
publications of individuals and centres. The questionnaire
has been distributed at conferences (including the Inter-
national Society of Travel Medicine (ISTM) conference in
Budapest in May 2009), and there is an active collation
of e-mail addresses for travel medicine advisors in indi-
vidual countries, using websites, yellow fever vaccinating
centres, personal contacts, ISTM listings, and a publica-
tion in Eurosurveillance http://www.eurosurveillance.org/
ViewArticle.aspx?ArticleId=19245.
At the end of 2009, a broad coverage of travel medicine
providers in Europe has been achieved. All EU, European
Free Trade Association and candidate states are represented
by individuals who have responded to the survey. Those
countries with low response rates are actively followed up,
and participation from the new EU members and candidates
is especially important, as few data on travel medicine in
these countries are available. This real-time method has
proven ideal for the provision of data on all types of travel
medicine practitioners. Respondents can update their data,
and all health professionals, including tropical medicine
specialists, nurses, physicians, pharmacists, and scientists
involved in travel medicine, can be involved. In the future,
this ECDC resource listing will be a centre for dissemination
of information relating to travel medicine, for networking of
centres with similar interests, and for identiﬁcation of Euro-
pean institutions with particular expertise in migrant health.
The contents of the database are not available to third
parties, and all data collected belong to the ECDC. To date,
over 900 Europeans have completed some parts or all of the
questionnaire, and a preliminary analysis will be reported in
January 2010.
2. A second tool is the structured interview (Box 1) to
enable the creation of a concise document detailing the
status quo of travel medicine in member and allied
states. The structured phone/e-mail interview consists
of 11 questions, and is designed to provide a national
picture for each of the European countries. One or
two national experts in each country are approached
and asked to provide answers to the 11 questions. The
questions are distributed in advance, and the experts
are free to respond by e-mail or phone.
3. Finally, web searching is used to identify topics and com-
pile tables of websites relating to travel medicine, with a
focus on Europe and an overview of global resources
(Tables 1 and 2).
The landscape of Travel Medicine in
Europe
Within Europe, there is great diversity in the practice of tra-
vel medicine. Some countries have travel medicine societies,
and provide for an efﬁcient distribution of recommendations.
However, many countries have no national pre-travel guide-
lines and follow international recommendations such as
those provided by the WHO or the CDC.
Providers of travel medicine include tropical medical special-
ists, general practice nurses and physicians, specialist ‘travel
clinics’, occupational physicians, and pharmacists. There is
currently a dearth of guidelines regarding the required quali-
ﬁcation to practice travel medicine and regarding certiﬁca-
tion. Each country has a distinct provider type proﬁle, and
there is also variation in whether travel medicine (both pre-
travel and post-travel) is provided for in the private or public
sector. The provision of the yellow fever vaccine is usually
regulated by national or regional health authorities in each of
the member states and in the UK; there is a formal pro-
gramme of registration, training, and audit for yellow fever
vaccination centres (http://www.nathnac.org/ (last accessed
30 October 2009)).
Conclusions
The diversity of travel medicine practice in Europe is not,
per se, negative, and the harmonization of guidelines is not
BOX 1 Structured interview
1. Who are the main practitioners of travel medicine in your country? Please
assign a proportion (%)
– GPs
– Specialized travel clinics
– Nurse travel medicine advisors
– Occupational medicine physicians in companies/institutions (army, etc.)
– pharmacists
– infectious disease specialists
– clinics attached to academic institutions
– Other?
2. Is there a society of travel medicine in your country? If yes, what is its
composition? No. of members?
3. Does this society provide guidelines on travel medicine? Website?
4. If yes, how are these guidelines distributed and how often are they updated?
5. If no, do travel medicine practitioners follow WHO guidelines or other?
6. Is there a central body in charge of yellow fever vaccinating individuals or sites?
7. Are there special requirements including training required for yellow fever
vaccination sites?
8. Are there centres in your country with expertise in migration medicine?
9. What do you see as major deﬁcit areas in travel medicine in your country?
10. Do you have ideas as to how travel medicine practice could be improved in
your country?
11. Do you think accreditation in travel medicine is necessary? In what form?
Certiﬁcate in Travel Medicine?
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necessarily the ultimate goal. There is, however, great
potential in Europe for ﬁnding common ground in travel
medicine practice, for establishing evidence-based advice,
and for optimizing practice by learning from neighbour
states, as each country has a different type of expertise.
This ﬁrst tentative step, a collaboration between ISTM,
ECDC, and EuroTravNet, which aims to deﬁne the current
situation of travel medicine in the EU and allied countries,
may prove to be a giant leap forwards for travel medicine
in Europe.
TABLE 2. Some travel medicine websites of global interest
WHO International Travel and Health http://www.who.int/ith/en/index.html
CDC Centers for Disease Control and
Prevention
http://wwwn.cdc.gov/travel/default.aspx
TRAVAX In English Subscription needed http://www.travax.scot.nhs.uk/
Tropimed In English, French and German Subscription needed http://www.astral.ch/ALL/tropimed.htm
ISTM International Society of Travel
Medicine
Parts of the website
are for members only
http://www.istm.org
MASTA MASTA, Medical Advisory
Service for Travellers
Subscription needed http://www.masta.org/
Worldwise New Zealand travel health http://www.worldwise.co.nz)
Travel Health
Online (Shoreland)
In English http://www.tripprep.com/
Travellers Medical &Vaccination
Center
Australian travel health advice http://www.tmvc.com.au/
National Travel Health Network
and Centre, NaTHNaC
Yellow fever vaccination centres
in the UK
http://www.nathnac.org/travel/factsheets/YF.htm
TABLE 1. Some travel medicine websites in European Union countries*
Austria http://www.reisemed.at/
Belgium http://www.itg.be/ITG/GeneralSite/GeneralPage.asp?Page=Medische+Diensten+%2D+Reisgeneeskunde&HT=Medische+Diensten&
ST=Reisgeneeskunde
Bulgaria http://74.125.43.132/translate_c?hl=de&sl=bg&u=http://www.ncipd.org/&prev=/search%3Fq%3Dministry%2Bof%2Bhealth%
2Bbulgaria%26hl%
3Dde%26client%3Dsafari%26rls%3Dde-de&rurl=translate.google.com&usg=ALkJrhivxwzLqTKPtOFkmQv8456bvOUuiA
Croatia http://www.mzss.hr/hr
Czech Republic http://www.mzcr.cz/Verejne/Default.aspx
http://www.e-globals.net/web/ordinace/eng/info_cestovatele.asp
Denmark http://www.ssi.dk/sw162.asp
Estonia http://translate.google.com/translate?hl=de&sl=et&u=http://www.tervisekaitse.ee/&ei=N3pcSpOZCceMjAfDgIHjDQ&sa=X&
oi=translate&resnum=1&ct=result&prev=/search%3Fq%3Destonian%2Bhealth%2Bprotection%2Binspectorate%26hl%3Dde%
26client%3Dsafari%26rls%3Dde-de
France http://www.diplomatie.fr/voyageurs/etrangers/avis/conseils/cartlst.asp
http://www.invs.sante.fr/beh/2009/23_24/beh_23_24_2009.pdf
Macedonia http://www.iph.mk/
Germany http://www.dtg.de
http://www.crm.de
Greece http://www.keel.org.gr/
Hungary http://www.antsz.hu/
Iceland http://www.landlaeknir.is/
Ireland http://tmb.exodus.ie/latest.asp
http://foreignaffairs.gov.ie/home/index.aspx?id=275
Italy http://www.ministerosalute.it/malattieInfettive/paginaMenuMalattieInfettive.jsp?menu=viaggiatori&lingua=italiano
Latvia http://www.lic.gov.lv/index.php?p=1151&pp=464&lang=259
Lithuania http://www.ulpkc.lt/tekstai/proﬁlaktika/keliautojams%20rekomendacijos%202009.pdf
http://www.ulpkc.lt/ulpkc.imuno.php
Luxembourg http://www.sante.public.lu/fr/rester-bonne-sante/voyages/index.html
Malta http://www.health.gov.mt/publications/index.htm
The Netherlands http://www.lcr.nl/
Norway http://www.fhi.no/eway/default.aspx?pid=233&trg=MainArea_5661&MainArea_5661=5631:0:15,2386:1:0:0:::0:0
Poland http://www.biuletyn.abip.pl/ucmmit/
Portugal http://www.ihmt.unl.pt/ConsultadoViajante/consulta.asp
Romania http://www.ispb.ro/
Slovakia http://www.ﬁtcom.sk/
Slovenia http://www.ivz.si/
Spain http://www.msc.es/en/ciudadanos/proteccionSalud/vacunaciones/docs/recoVacunasAdultos.pdf
http://www.msc.es/en/ciudadanos/proteccionSalud/vacunaciones/viajero/home.htm
Sweden http://www.vaccination.nu/
http://1177.se/start.asp
Switzerland http://www.bag.admin.ch/infekt/publ/bulletin/d/reisemed%20bu42.pdf
UK http://www.doh.gov.uk/traveladvice/
http://www.doh.gov.uk/traveladvice/tables.htm
http://www.ﬁtfortravel.scot.nhs.uk/home.aspx
http://www.travelhealth.co.uk/
*Disclaimer: These websites were identiﬁed by web-searching. The listing is not an endorsement of the contents or recommendations contained in the websites listed.
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